BORIC ACID

BORIC ACID was reported 355 times

BORIC ACID is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OTITIS MEDIA FUNGAL 5 0.4545
1 MYOCARDIAL REPERFUSION INJURY 9 0.2368
2 PSEUDOSEPSIS 2 0.1667
3 SYNOVIAL FLUID ANALYSIS 13 0.1494
4 SCROTUM EROSION 1 0.0500
5 RED BLOOD CELL SEDIMENTATION RATE DECREASED 11 0.0421
6 TURBINOPLASTY 1 0.0370
7 SYNOVIAL DISORDER 13 0.0286
8 TENOSYNOVITIS STENOSANS 13 0.0233
9 HEPATIC ENZYME DECREASED 10 0.0223
10 GASTROINTESTINAL TOXICITY 106 0.0220
11 LACK OF INFUSION SITE ROTATION 1 0.0208
12 C-REACTIVE PROTEIN ABNORMAL 96 0.0150
13 PULMONARY TOXICITY 105 0.0148
14 UNADJUSTED DOSE ADMINISTERED 1 0.0147
15 EYELID HAEMATOMA 1 0.0147
16 MYRINGITIS 1 0.0135
17 APALLIC SYNDROME 9 0.0124
18 ALLERGY TO CHEMICALS 14 0.0112
19 BLOOD VISCOSITY ABNORMAL 1 0.0105
20 DISABILITY ASSESSMENT SCALE SCORE INCREASED 3 0.0098
21 HEALTH ASSESSMENT QUESTIONNAIRE SCORE INCREASED 1 0.0096
22 CHEMICAL BURN OF GENITALIA 1 0.0082
23 SCLERITIS 13 0.0081
24 PANCREATIC ENZYMES DECREASED 1 0.0078
25 SOLAR DERMATITIS 2 0.0074
26 BONE ATROPHY 1 0.0059
27 PLEURITIC PAIN 15 0.0054
28 JOINT INJURY 105 0.0049
29 HEPATOTOXICITY 109 0.0049
30 RHEUMATOID NODULE 13 0.0047
31 TENOSYNOVITIS 13 0.0047
32 EXPOSURE VIA INHALATION 1 0.0046
33 MUCOSAL DRYNESS 9 0.0045
34 GRIP STRENGTH 1 0.0044
35 CREPITATIONS 13 0.0044
36 CUSHINGOID 14 0.0044
37 VAGINAL MYCOSIS 1 0.0043
38 ANTINUCLEAR ANTIBODY POSITIVE 13 0.0040
39 SYMBLEPHARON 1 0.0038
40 SCROTAL ULCER 1 0.0038
41 JOINT STIFFNESS 97 0.0037
42 AVULSION FRACTURE 1 0.0035
43 BACTERIAL VULVOVAGINITIS 1 0.0035
44 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 9 0.0034
45 FACET JOINT SYNDROME 11 0.0034
46 CATHETER SITE IRRITATION 1 0.0030
47 BRAIN DEATH 9 0.0029
48 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
49 SYNOVIAL CYST 13 0.0028
50 TOOTH REPAIR 1 0.0028
51 PERIODIC LIMB MOVEMENT DISORDER 1 0.0027
52 BACTERIAL VAGINOSIS 4 0.0026
53 CAT SCRATCH DISEASE 1 0.0025
54 BLOOD PHOSPHORUS DECREASED 9 0.0025
55 HAEMOGLOBIN INCREASED 11 0.0024
56 LUPUS VULGARIS 3 0.0024
57 TYMPANIC MEMBRANE PERFORATION 4 0.0024
58 THERAPY NON-RESPONDER 106 0.0024
59 CERVICITIS 1 0.0022
60 ECZEMA HERPETICUM 1 0.0022
61 MUSCULOSKELETAL PAIN 108 0.0021
62 LEUKOPLAKIA ORAL 1 0.0019
63 VENTRICULAR ARRHYTHMIA 7 0.0019
64 JOINT EFFUSION 13 0.0019
65 INADEQUATE DIET 1 0.0019
66 CORNEAL EROSION 1 0.0019
67 INTRACRANIAL HAEMATOMA 1 0.0018
68 IRREGULAR BREATHING 1 0.0017
69 URINARY TRACT INFECTION PSEUDOMONAL 1 0.0017
70 ARTHROPATHY 90 0.0016
71 BLOOD PRESSURE SYSTOLIC ABNORMAL 4 0.0016
72 NEOPLASM MALIGNANT 108 0.0016
73 LOWER EXTREMITY MASS 1 0.0016
74 DEFAECATION DISORDER 1 0.0015
75 DUODENAL ULCER PERFORATION 11 0.0015
76 FOLLICULITIS 15 0.0014
77 FUNGAL OESOPHAGITIS 1 0.0014
78 CERVICAL RADICULOPATHY 1 0.0014
79 DEFORMITY 13 0.0014
80 FLANK PAIN 13 0.0014
81 LIP EROSION 1 0.0014
82 ATELECTASIS 13 0.0013
83 EOSINOPHIL COUNT ABNORMAL 1 0.0013
84 TREATMENT FAILURE 110 0.0013
85 CONTRAINDICATED PRODUCT ADMINISTERED 39 0.0013
86 PUSTULE 3 0.0013
87 MUSCULOSKELETAL STIFFNESS 110 0.0013
88 TENDERNESS 13 0.0012
89 BREAST OPERATION 1 0.0012
90 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 87 0.0012
91 BLOOD PRESSURE DIASTOLIC ABNORMAL 3 0.0012
92 HELICOBACTER INFECTION 12 0.0012
93 BURSITIS 14 0.0012
94 TORSADE DE POINTES 9 0.0011
95 EXTREMITY NECROSIS 2 0.0011
96 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
97 PUNCTATE KERATITIS 1 0.0011
98 HAND DEFORMITY 14 0.0011
99 QUALITY OF LIFE DECREASED 14 0.0010
100 INFUSION SITE NODULE 1 0.0010
101 MASTOIDITIS 1 0.0010
102 NODULE 13 0.0010
103 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
104 JOINT RANGE OF MOTION DECREASED 13 0.0010
105 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
106 RESPIRATORY TRACT IRRITATION 1 0.0010
107 THERAPEUTIC PRODUCT EFFECT DECREASED 42 0.0009
108 JOINT SWELLING 112 0.0009
109 CORNEAL DISORDER 2 0.0009
110 DRUG INTOLERANCE 88 0.0009
111 BRAIN INJURY 9 0.0009
112 ULCER 14 0.0009
113 DISLOCATION OF VERTEBRA 2 0.0009
114 ACUTE PRERENAL FAILURE 1 0.0009
115 STRESS CARDIOMYOPATHY 5 0.0009
116 MUSCLE INJURY 7 0.0008
117 BRONCHIAL HYPERREACTIVITY 1 0.0008
118 SECONDARY IMMUNODEFICIENCY 1 0.0008
119 OTITIS EXTERNA 1 0.0008
120 ORAL MUCOSA EROSION 1 0.0008
121 VENTRICULAR FIBRILLATION 9 0.0008
122 CONJUNCTIVITIS 15 0.0008
123 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
124 INFECTION 111 0.0008
125 EAR CONGESTION 2 0.0007
126 FEELING JITTERY 14 0.0007
127 ULCERATIVE KERATITIS 2 0.0007
128 INFUSION SITE RASH 1 0.0007
129 INFLAMMATION 37 0.0007
130 STATUS EPILEPTICUS 8 0.0007
131 PORPHYRIA ACUTE 1 0.0007
132 PHOTOPHOBIA 13 0.0007
133 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
134 RASH MACULO-PAPULAR 15 0.0007
135 STEROID DIABETES 1 0.0007
136 LIPASE INCREASED 5 0.0007
137 PNEUMONIA PSEUDOMONAL 1 0.0007
138 ORAL MUCOSAL ERUPTION 1 0.0007
139 BLOOD PRESSURE DIASTOLIC INCREASED 3 0.0006
140 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
141 INFUSION SITE PRURITUS 2 0.0006
142 SCIATICA 10 0.0006
143 EXPOSURE TO TOXIC AGENT 2 0.0006
144 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 4 0.0006
145 IMPAIRED WORK ABILITY 13 0.0006
146 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
147 ACUTE SINUSITIS 1 0.0006
148 RETINITIS 1 0.0006
149 TREATMENT DELAYED 1 0.0006
150 FIBROMYALGIA 14 0.0006
151 BONE EROSION 2 0.0006
152 VULVOVAGINAL SWELLING 1 0.0005
153 RHEUMATOID ARTHRITIS 62 0.0005
154 MECHANICAL VENTILATION 1 0.0005
155 MENOMETRORRHAGIA 1 0.0005
156 ADRENAL DISORDER 1 0.0005
157 BICYTOPENIA 1 0.0005
158 UNDERWEIGHT 1 0.0005
159 MYOCLONUS 6 0.0005
160 SKIN ULCER 13 0.0005
161 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
162 GLOSSODYNIA 11 0.0005
163 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
164 WALKING DISABILITY 1 0.0005
165 BLOOD SODIUM DECREASED 9 0.0005
166 LUNG ABSCESS 1 0.0005
167 IMPAIRED HEALING 15 0.0005
168 RED BLOOD CELL COUNT DECREASED 13 0.0005
169 EAR INFECTION 12 0.0005
170 TEMPERATURE REGULATION DISORDER 1 0.0004
171 SKIN INFECTION 5 0.0004
172 SINUS PAIN 1 0.0004
173 SINUS OPERATION 1 0.0004
174 RADIUS FRACTURE 1 0.0004
175 PULSE ABNORMAL 1 0.0004
176 BONE DENSITY DECREASED 13 0.0004
177 PRODUCT PACKAGING CONFUSION 1 0.0004
178 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
179 ENDODONTIC PROCEDURE 1 0.0004
180 ABNORMAL UTERINE BLEEDING 1 0.0004
181 C-REACTIVE PROTEIN INCREASED 14 0.0004
182 PAIN IN EXTREMITY 113 0.0004
183 BREAST SWELLING 1 0.0004
184 WOUND INFECTION 4 0.0004
185 MACULE 1 0.0004
186 EAR PAIN 7 0.0004
187 CONDITION AGGRAVATED 109 0.0004
188 LUNG CONSOLIDATION 1 0.0004
189 DRUG TOLERANCE DECREASED 1 0.0004
190 RETINAL VEIN OCCLUSION 1 0.0003
191 HERPES VIRUS INFECTION 2 0.0003
192 RASH PRURITIC 18 0.0003
193 GANGRENE 2 0.0003
194 INTERSTITIAL LUNG DISEASE 16 0.0003
195 EYE INJURY 1 0.0003
196 PATHOGEN RESISTANCE 3 0.0003
197 KERATITIS 1 0.0003
198 EXOSTOSIS 3 0.0003
199 VULVOVAGINAL BURNING SENSATION 2 0.0003
200 TYPE 2 DIABETES MELLITUS 11 0.0003
201 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
202 PORTAL HYPERTENSION 1 0.0003
203 MULTIPLE-DRUG RESISTANCE 1 0.0003
204 DRY EYE 16 0.0003
205 RESPIRATORY RATE DECREASED 1 0.0003
206 INFUSION SITE SWELLING 2 0.0003
207 POISONING DELIBERATE 3 0.0003
208 PNEUMONIA VIRAL 1 0.0003
209 VENTRICULAR HYPOKINESIA 1 0.0003
210 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
211 PORTAL VEIN THROMBOSIS 1 0.0003
212 BREAST CANCER STAGE III 2 0.0003
213 APPLICATION SITE VESICLES 2 0.0003
214 CANDIDA INFECTION 5 0.0003
215 OCULAR HYPERAEMIA 14 0.0003
216 TOOTH ABSCESS 3 0.0003
217 LIVER DISORDER 13 0.0003
218 PERIPHERAL SWELLING 45 0.0003
219 REGURGITATION 1 0.0003
220 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
221 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
222 MOUTH ULCERATION 6 0.0003
223 DEPRESSIVE SYMPTOM 1 0.0003
224 MACULOPATHY 1 0.0003
225 CONJUNCTIVAL HYPERAEMIA 1 0.0003
226 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
227 ARTHRALGIA 114 0.0003
228 FOOT DEFORMITY 3 0.0003
229 EYE PAIN 15 0.0003
230 LUNG DISORDER 13 0.0003
231 PARANASAL SINUS DISCOMFORT 1 0.0003
232 DERMATITIS CONTACT 3 0.0003
233 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
234 EYE IRRITATION 15 0.0003
235 VENOUS THROMBOSIS 1 0.0003
236 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
237 MEDICATION ERROR 14 0.0003
238 OBSTRUCTION 1 0.0003
239 BLEPHARITIS 1 0.0002
240 PERIPHERAL VENOUS DISEASE 1 0.0002
241 PERIPHERAL ISCHAEMIA 1 0.0002
242 DYSURIA 9 0.0002
243 LEG AMPUTATION 1 0.0002
244 PEMPHIGUS 3 0.0002
245 ROAD TRAFFIC ACCIDENT 10 0.0002
246 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
247 INFUSION SITE ERYTHEMA 2 0.0002
248 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
249 HEPATIC PAIN 1 0.0002
250 DRUG RESISTANCE 6 0.0002
251 IRRITABLE BOWEL SYNDROME 5 0.0002
252 ARRHYTHMIA 11 0.0002
253 TONGUE DISCOLOURATION 1 0.0002
254 VULVOVAGINAL DISCOMFORT 1 0.0002
255 ADVERSE REACTION 3 0.0002
256 BLOOD CREATINE INCREASED 1 0.0002
257 ANAL INCONTINENCE 2 0.0002
258 HEAVY MENSTRUAL BLEEDING 2 0.0002
259 TOOTHACHE 4 0.0002
260 OSTEOMYELITIS 4 0.0002
261 PELVIC PAIN 4 0.0002
262 WHEEZING 13 0.0002
263 DYSPAREUNIA 1 0.0002
264 HYPOKALAEMIA 10 0.0002
265 CARDIO-RESPIRATORY ARREST 9 0.0002
266 FEELING OF DESPAIR 1 0.0002
267 CARPAL TUNNEL SYNDROME 3 0.0002
268 VAGINAL INFECTION 1 0.0002
269 INFUSION RELATED REACTION 14 0.0002
270 COLITIS MICROSCOPIC 1 0.0002
271 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
272 FUNGAL INFECTION 7 0.0002
273 VULVOVAGINAL PAIN 1 0.0002
274 HYPERCHOLESTEROLAEMIA 2 0.0002
275 AUTOIMMUNE DISORDER 2 0.0002
276 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
277 SINUSITIS 21 0.0002
278 PHARYNGEAL SWELLING 2 0.0002
279 STAPHYLOCOCCAL SEPSIS 1 0.0002
280 SWELLING FACE 13 0.0002
281 TOXIC SKIN ERUPTION 2 0.0002
282 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
283 BLISTER 11 0.0002
284 CEREBRAL ISCHAEMIA 1 0.0002
285 APLASTIC ANAEMIA 1 0.0002
286 ANAL FISSURE 1 0.0002
287 GINGIVITIS 1 0.0002
288 DRY MOUTH 15 0.0002
289 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
290 ASPIRATION 2 0.0002
291 JAW DISORDER 1 0.0002
292 ASTHENOPIA 1 0.0002
293 CARDIAC ARREST 15 0.0002
294 SWELLING 17 0.0002
295 HYPERKERATOSIS 1 0.0002
296 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
297 NECROSIS 1 0.0002
298 PULMONARY OEDEMA 8 0.0002
299 SCAB 2 0.0002
300 MICTURITION URGENCY 2 0.0002
301 MOUTH SWELLING 1 0.0002
302 PRODUCT LABEL CONFUSION 1 0.0002
303 HYPERTRIGLYCERIDAEMIA 1 0.0002
304 BRADYCARDIA 9 0.0002
305 COVID-19 PNEUMONIA 2 0.0002
306 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
307 BLOOD PRESSURE FLUCTUATION 4 0.0002
308 ARTHRITIS 13 0.0002
309 THROMBOSIS 13 0.0002
310 OLIGURIA 1 0.0002
311 HEPATIC CIRRHOSIS 3 0.0002
312 DERMATITIS ALLERGIC 2 0.0002
313 ENTERITIS 1 0.0002
314 LOWER LIMB FRACTURE 3 0.0002
315 ANGINA UNSTABLE 1 0.0002
316 ORAL HERPES 3 0.0002
317 BREAST MASS 1 0.0001
318 ULCER HAEMORRHAGE 1 0.0001
319 ENCEPHALITIS 1 0.0001
320 LARGE INTESTINE PERFORATION 1 0.0001
321 HEART RATE DECREASED 5 0.0001
322 TONGUE DISORDER 1 0.0001
323 BLOOD CREATININE INCREASED 9 0.0001
324 RASH PUSTULAR 1 0.0001
325 PSYCHIATRIC SYMPTOM 1 0.0001
326 ORAL PAIN 3 0.0001
327 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
328 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
329 FOOD ALLERGY 1 0.0001
330 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
331 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
332 MULTIPLE ALLERGIES 1 0.0001
333 SLEEP DISORDER 9 0.0001
334 HAEMOGLOBIN DECREASED 13 0.0001
335 PULMONARY EMBOLISM 12 0.0001
336 NASAL DISCOMFORT 1 0.0001
337 RENAL CYST 1 0.0001
338 CYSTITIS 4 0.0001
339 LOCALISED INFECTION 3 0.0001
340 EMBOLISM 1 0.0001
341 SECOND PRIMARY MALIGNANCY 1 0.0001
342 PERICARDITIS 2 0.0001
343 SENSATION OF FOREIGN BODY 1 0.0001
344 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
345 ANURIA 1 0.0001
346 MUSCLE STRAIN 1 0.0001
347 STOMATITIS 7 0.0001
348 DELIRIUM 4 0.0001
349 VAGINAL HAEMORRHAGE 5 0.0001
350 URINE OUTPUT DECREASED 1 0.0001
351 MUSCULAR WEAKNESS 13 0.0001
352 GRIP STRENGTH DECREASED 1 0.0001
353 VISUAL IMPAIRMENT 14 0.0001
354 DRUG ERUPTION 2 0.0001
355 ERYTHEMA 23 0.0001
356 RETINAL DETACHMENT 1 0.0001
357 AGRANULOCYTOSIS 2 0.0001
358 SPINAL DISORDER 1 0.0001
359 EYE INFLAMMATION 1 0.0001
360 PULMONARY FIBROSIS 2 0.0001
361 PRESCRIBED OVERDOSE 2 0.0001
362 INFLAMMATORY BOWEL DISEASE 1 0.0001
363 SALIVARY HYPERSECRETION 1 0.0001
364 HYPERTENSION 21 0.0001
365 PNEUMONIA 32 0.0001
366 VAGINAL DISCHARGE 1 0.0001
367 ILL-DEFINED DISORDER 6 0.0001
368 EYELID PTOSIS 1 0.0001
369 SLUGGISHNESS 1 0.0001
370 WEIGHT FLUCTUATION 1 0.0001
371 PRODUCT ODOUR ABNORMAL 1 0.0001
372 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
373 JOINT DISLOCATION 1 0.0001
374 NIGHT SWEATS 3 0.0001
375 LACTIC ACIDOSIS 3 0.0001
376 BIPOLAR DISORDER 1 0.0001
377 SKIN LACERATION 1 0.0001
378 DRUG INEFFECTIVE 121 0.0001
379 PRODUCT PRESCRIBING ISSUE 2 0.0001
380 INJECTION SITE NODULE 1 0.0001
381 TOOTH FRACTURE 1 0.0001
382 URINARY RETENTION 3 0.0001
383 EYE INFECTION 1 0.0001
384 SHOCK 2 0.0001
385 HYPOAESTHESIA 13 0.0001
386 MUSCLE TWITCHING 2 0.0001
387 RASH MACULAR 3 0.0001
388 HEPATITIS C 1 0.0001
389 PHARYNGITIS 1 0.0001
390 TOOTH EXTRACTION 1 0.0001
391 INJECTION SITE DISCOLOURATION 1 0.0001
392 POISONING 1 0.0001
393 FEELING ABNORMAL 19 0.0001
394 INTRAOCULAR PRESSURE INCREASED 1 0.0001
395 ROTATOR CUFF SYNDROME 1 0.0001
396 BACK PAIN 18 0.0001
397 RASH GENERALISED 2 0.0001
398 EXPOSURE VIA SKIN CONTACT 2 0.0001
399 TOXICITY TO VARIOUS AGENTS 13 0.0001
400 DEAFNESS 2 0.0001
401 MYALGIA 13 0.0001
402 ORAL CANDIDIASIS 1 0.0001
403 ANKYLOSING SPONDYLITIS 1 0.0001
404 TOOTH INFECTION 1 0.0001
405 PYREXIA 26 0.0001
406 MALIGNANT MELANOMA 1 0.0001
407 UVEITIS 1 0.0001
408 PNEUMONITIS 2 0.0001
409 ACUTE HEPATIC FAILURE 1 0.0001
410 ABDOMINAL PAIN 17 0.0001
411 CORONARY ARTERY OCCLUSION 1 0.0001
412 SKIN LESION 2 0.0001
413 RESPIRATORY DISTRESS 2 0.0001
414 COMPLETED SUICIDE 6 0.0001
415 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
416 SEASONAL ALLERGY 1 0.0001
417 SINUS TACHYCARDIA 1 0.0001
418 RECTAL HAEMORRHAGE 3 0.0001
419 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
420 RASH 30 0.0001
421 CARDIOMYOPATHY 1 0.0001
422 THROAT IRRITATION 3 0.0001
423 RESPIRATORY DISORDER 2 0.0001
424 EPILEPSY 2 0.0001
425 FEELING HOT 4 0.0001
426 PRURITUS 25 0.0001
427 DEVICE RELATED INFECTION 1 0.0001
428 THYROID DISORDER 1 0.0001
429 HYPERSENSITIVITY 12 0.0001
430 LIMB DISCOMFORT 2 0.0001
431 MUSCULOSKELETAL CHEST PAIN 1 0.0001
432 EJECTION FRACTION DECREASED 1 0.0001
433 BASAL CELL CARCINOMA 1 0.0001
434 DRUG-INDUCED LIVER INJURY 2 0.0001
435 OBESITY 1 0.0001
436 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
437 INTENTIONAL OVERDOSE 4 0.0001
438 MULTIPLE FRACTURES 1 0.0001
439 EYE DISORDER 2 0.0001
440 HEART RATE INCREASED 6 0.0001
441 COAGULOPATHY 1 0.0001
442 INJECTION SITE PRURITUS 4 0.0001
443 CELLULITIS 3 0.0001
444 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
445 MUSCULOSKELETAL DISCOMFORT 1 0.0001
446 ECZEMA 3 0.0001
447 INJURY 4 0.0001
448 HEAD DISCOMFORT 1 0.0001
449 GALLBLADDER DISORDER 1 0.0001
450 GASTROINTESTINAL DISORDER 5 0.0001
451 SYNOVITIS 1 0.0001
452 PANIC ATTACK 2 0.0001
453 OFF LABEL USE 48 0.0001
454 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
455 NASOPHARYNGITIS 10 0.0001
456 BRONCHITIS 4 0.0001
457 BACTERIAL INFECTION 1 0.0001
458 OXYGEN SATURATION DECREASED 3 0.0001
459 FOOT FRACTURE 1 0.0001
460 BLOOD URINE PRESENT 1 0.0001
461 GASTRIC ULCER 1 0.0001
462 PAIN 32 0.0001
463 CHOLESTASIS 1 0.0001
464 GLAUCOMA 1 0.0001
465 HAEMORRHOIDS 1 0.0001
466 SKIN FISSURES 1 0.0001
467 DISABILITY 1 0.0001
468 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
469 SINUS DISORDER 1 0.0001
470 CATARACT 3 0.0001
471 UPPER LIMB FRACTURE 1 0.0001
472 MALAISE 22 0.0001
473 WEIGHT DECREASED 14 0.0001
474 PRESCRIBED UNDERDOSE 1 0.0001
475 PSORIATIC ARTHROPATHY 2 0.0000
476 ANXIETY 14 0.0000
477 WEIGHT INCREASED 11 0.0000
478 BODY TEMPERATURE INCREASED 1 0.0000
479 DERMATITIS 1 0.0000
480 EATING DISORDER 1 0.0000
481 POOR QUALITY SLEEP 1 0.0000
482 SKIN CANCER 1 0.0000
483 PRURITUS GENERALISED 1 0.0000
484 DEVICE DISLOCATION 2 0.0000
485 SEPTIC SHOCK 2 0.0000
486 COLITIS ULCERATIVE 2 0.0000
487 CHROMATURIA 1 0.0000
488 HEART RATE IRREGULAR 1 0.0000
489 DYSPNOEA 25 0.0000
490 FATIGUE 33 0.0000
491 COMA 2 0.0000
492 MIGRAINE 4 0.0000
493 URTICARIA 7 0.0000
494 MENTAL IMPAIRMENT 1 0.0000
495 URINARY TRACT INFECTION 7 0.0000
496 LIVER INJURY 1 0.0000
497 DIZZINESS 20 0.0000
498 AGEUSIA 1 0.0000
499 FLUID RETENTION 2 0.0000
500 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
501 ANAPHYLACTIC SHOCK 1 0.0000
502 HAEMATOMA 1 0.0000
503 DIPLOPIA 1 0.0000
504 RESPIRATORY TRACT INFECTION 1 0.0000
505 ANHEDONIA 1 0.0000
506 DERMATITIS ATOPIC 2 0.0000
507 MENSTRUATION IRREGULAR 1 0.0000
508 FEAR 1 0.0000
509 CONFUSIONAL STATE 6 0.0000
510 OEDEMA 2 0.0000
511 MOOD ALTERED 1 0.0000
512 TREATMENT NONCOMPLIANCE 2 0.0000
513 RESPIRATORY ARREST 1 0.0000
514 PROCEDURAL PAIN 1 0.0000
515 FEELING COLD 1 0.0000
516 NECK PAIN 2 0.0000
517 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
518 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
519 FLATULENCE 2 0.0000
520 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
521 SEIZURE 4 0.0000
522 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
523 LABORATORY TEST ABNORMAL 1 0.0000
524 INJECTION SITE RASH 1 0.0000
525 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
526 CONSTIPATION 7 0.0000
527 NAUSEA 25 0.0000
528 CHOLELITHIASIS 1 0.0000
529 LIP SWELLING 1 0.0000
530 GAIT INABILITY 1 0.0000
531 CHEST DISCOMFORT 3 0.0000
532 HAEMATURIA 1 0.0000
533 GASTRIC DISORDER 1 0.0000
534 ILLNESS 3 0.0000
535 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
536 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
537 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
538 MOBILITY DECREASED 2 0.0000
539 RESPIRATORY FAILURE 2 0.0000
540 INJECTION SITE MASS 1 0.0000
541 HEPATIC FUNCTION ABNORMAL 1 0.0000
542 DYSPNOEA EXERTIONAL 1 0.0000
543 ASTHMA 3 0.0000
544 COLITIS 1 0.0000
545 DIABETES MELLITUS 2 0.0000
546 ACUTE KIDNEY INJURY 4 0.0000
547 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
548 HOSPITALISATION 4 0.0000
549 CARDIAC FAILURE 2 0.0000
550 DIARRHOEA 16 0.0000
551 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
552 DYSKINESIA 1 0.0000
553 BLINDNESS 1 0.0000
554 OSTEOPOROSIS 1 0.0000
555 ABDOMINAL PAIN UPPER 5 0.0000
556 INJECTION SITE ERYTHEMA 3 0.0000
557 POLLAKIURIA 1 0.0000
558 SKIN EXFOLIATION 2 0.0000
559 OSTEOARTHRITIS 1 0.0000
560 VOMITING 11 0.0000
561 HYPOACUSIS 1 0.0000
562 OVERDOSE 5 0.0000
563 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
564 COVID-19 4 0.0000
565 DEHYDRATION 3 0.0000
566 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
567 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
568 MEMORY IMPAIRMENT 3 0.0000
569 SKIN IRRITATION 1 0.0000
570 TINNITUS 1 0.0000
571 SKIN DISCOLOURATION 1 0.0000
572 ADVERSE EVENT 2 0.0000
573 OROPHARYNGEAL PAIN 2 0.0000
574 RENAL DISORDER 1 0.0000
575 CONTUSION 2 0.0000
576 HEADACHE 13 0.0000
577 ATRIAL FIBRILLATION 2 0.0000
578 PRODUCT DOSE OMISSION ISSUE 6 0.0000
579 ALOPECIA 4 0.0000
580 DYSPEPSIA 2 0.0000
581 LEUKOPENIA 1 0.0000
582 HYPOTENSION 4 0.0000
583 FLUSHING 2 0.0000
584 ABDOMINAL DISTENSION 2 0.0000
585 SPEECH DISORDER 1 0.0000
586 PARAESTHESIA 3 0.0000
587 PANCREATITIS 1 0.0000
588 DEPRESSED MOOD 1 0.0000
589 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
590 INSOMNIA 5 0.0000
591 DRUG EFFECT DECREASED 1 0.0000
592 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
593 ANAPHYLACTIC REACTION 1 0.0000
594 SEPSIS 2 0.0000
595 PANCYTOPENIA 1 0.0000
596 COUGH 5 0.0000
597 HYPONATRAEMIA 1 0.0000
598 DECREASED APPETITE 4 0.0000
599 DYSPHONIA 1 0.0000
600 PALPITATIONS 2 0.0000
601 CHILLS 2 0.0000
602 SURGERY 1 0.0000
603 NASAL CONGESTION 1 0.0000
604 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
605 THERAPEUTIC RESPONSE DECREASED 1 0.0000
606 SUICIDE ATTEMPT 1 0.0000
607 PLEURAL EFFUSION 1 0.0000
608 VERTIGO 1 0.0000
609 DISCOMFORT 1 0.0000
610 MUSCLE SPASMS 3 0.0000
611 CHEST PAIN 3 0.0000
612 PRODUCT USE ISSUE 3 0.0000
613 ANAEMIA 3 0.0000
614 LOSS OF CONSCIOUSNESS 2 0.0000
615 HYPERHIDROSIS 2 0.0000
616 DEVICE EXPULSION 1 0.0000
617 DEEP VEIN THROMBOSIS 1 0.0000
618 AMNESIA 1 0.0000
619 DEVICE DIFFICULT TO USE 1 0.0000
620 RENAL FAILURE 2 0.0000
621 BLOOD PRESSURE DECREASED 1 0.0000
622 INJECTION SITE REACTION 1 0.0000
623 BURNING SENSATION 1 0.0000
624 DEVICE MALFUNCTION 1 0.0000
625 SKIN BURNING SENSATION 1 0.0000
626 HALLUCINATION 1 0.0000
627 UNEVALUABLE EVENT 1 0.0000
628 DEPRESSION 3 0.0000
629 CHRONIC KIDNEY DISEASE 1 0.0000
630 BLOOD PRESSURE INCREASED 2 0.0000
631 INJECTION SITE PAIN 4 0.0000
632 DRUG DOSE OMISSION BY DEVICE 1 0.0000
633 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
634 DRUG ABUSE 1 0.0000
635 ABDOMINAL DISCOMFORT 2 0.0000
636 INTENTIONAL PRODUCT MISUSE 1 0.0000
637 DRUG WITHDRAWAL SYNDROME 1 0.0000
638 TACHYCARDIA 1 0.0000
639 DEVICE ISSUE 1 0.0000
640 BREAST CANCER 1 0.0000
641 ASTHENIA 4 0.0000
642 DYSPHAGIA 1 0.0000
643 NEUROPATHY PERIPHERAL 1 0.0000
644 HAEMORRHAGE 1 0.0000
645 FALL 3 0.0000
646 INFLUENZA 1 0.0000
647 THROMBOCYTOPENIA 1 0.0000
648 INCORRECT DOSE ADMINISTERED 2 0.0000
649 EMOTIONAL DISTRESS 1 0.0000
650 OEDEMA PERIPHERAL 1 0.0000
651 PSORIASIS 1 0.0000
652 DRY SKIN 1 0.0000
653 PRODUCT QUALITY ISSUE 1 0.0000
654 DRUG INTERACTION 1 0.0000
655 NO ADVERSE EVENT 1 0.0000
656 BLOOD GLUCOSE INCREASED 1 0.0000
657 GAIT DISTURBANCE 1 0.0000
658 DEATH 3 0.0000